180 related articles for article (PubMed ID: 32341098)
1. Reduced Expression of the PP2A Methylesterase, PME-1, or the PP2A Methyltransferase, LCMT-1, Alters Sensitivity to Beta-Amyloid-Induced Cognitive and Electrophysiological Impairments in Mice.
Staniszewski A; Zhang H; Asam K; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE
J Neurosci; 2020 Jun; 40(23):4596-4608. PubMed ID: 32341098
[TBL] [Abstract][Full Text] [Related]
2. Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
Gnanaprakash M; Staniszewski A; Zhang H; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE
J Alzheimers Dis; 2021; 79(4):1813-1829. PubMed ID: 33459709
[TBL] [Abstract][Full Text] [Related]
3. PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments.
Nicholls RE; Sontag JM; Zhang H; Staniszewski A; Yan S; Kim CY; Yim M; Woodruff CM; Arning E; Wasek B; Yin D; Bottiglieri T; Sontag E; Kandel ER; Arancio O
Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3347-52. PubMed ID: 26951658
[TBL] [Abstract][Full Text] [Related]
4. Leucine Carboxyl Methyltransferase 1 (LCMT-1) Methylates Protein Phosphatase 4 (PP4) and Protein Phosphatase 6 (PP6) and Differentially Regulates the Stable Formation of Different PP4 Holoenzymes.
Hwang J; Lee JA; Pallas DC
J Biol Chem; 2016 Sep; 291(40):21008-21019. PubMed ID: 27507813
[TBL] [Abstract][Full Text] [Related]
5. Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.
Asam K; Staniszewski A; Zhang H; Melideo SL; Mazzeo A; Voronkov M; Huber KL; Pérez E; Stock M; Stock JB; Arancio O; Nicholls RE
PLoS One; 2017; 12(12):e0189413. PubMed ID: 29253878
[TBL] [Abstract][Full Text] [Related]
6. Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation.
Sontag JM; Nunbhakdi-Craig V; Montgomery L; Arning E; Bottiglieri T; Sontag E
J Neurosci; 2008 Nov; 28(45):11477-87. PubMed ID: 18987184
[TBL] [Abstract][Full Text] [Related]
7. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
8. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
[TBL] [Abstract][Full Text] [Related]
9. Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner.
Jackson JB; Pallas DC
Neoplasia; 2012 Jul; 14(7):585-99. PubMed ID: 22904676
[TBL] [Abstract][Full Text] [Related]
10. Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells.
Lee JA; Pallas DC
J Biol Chem; 2007 Oct; 282(42):30974-84. PubMed ID: 17724024
[TBL] [Abstract][Full Text] [Related]
11. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.
Jiang L; Huang M; Xu S; Wang Y; An P; Feng C; Chen X; Wei X; Han Y; Wang Q
Mol Neurobiol; 2016 Aug; 53(6):3832-3841. PubMed ID: 26160762
[TBL] [Abstract][Full Text] [Related]
12. Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein.
Tian H; Lu Y; Liu J; Liu W; Lu L; Duan C; Gao G; Yang H
Front Aging Neurosci; 2018; 10():173. PubMed ID: 29950985
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of microRNA-195 contributes to protein phosphatase-2A inactivation in rats with chronic brain hypoperfusion.
Liu CD; Wang Q; Zong DK; Pei SC; Yan Y; Yan ML; Sun LL; Hao YY; Mao M; Xing WJ; Ren H; Ai J
Neurobiol Aging; 2016 Sep; 45():76-87. PubMed ID: 27459928
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
[TBL] [Abstract][Full Text] [Related]
16. The structural basis for tight control of PP2A methylation and function by LCMT-1.
Stanevich V; Jiang L; Satyshur KA; Li Y; Jeffrey PD; Li Z; Menden P; Semmelhack MF; Xing Y
Mol Cell; 2011 Feb; 41(3):331-42. PubMed ID: 21292165
[TBL] [Abstract][Full Text] [Related]
17. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
[TBL] [Abstract][Full Text] [Related]
18. Danshensu attenuates scopolamine and amyloid-β-induced cognitive impairments through the activation of PKA-CREB signaling in mice.
Bae HJ; Sowndhararajan K; Park HB; Kim SY; Kim S; Kim DH; Choi JW; Jang DS; Ryu JH; Park SJ
Neurochem Int; 2019 Dec; 131():104537. PubMed ID: 31425745
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
[TBL] [Abstract][Full Text] [Related]
20. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
